Role of CRISPR/Cas9 in the treatment of Duchenne muscular dystrophy and its delivery strategies

Publisher:
Elsevier BV
Publication Type:
Journal Article
Citation:
Life Sciences, 2023, pp. 122003-122003
Issue Date:
2023-08
Filename Description Size
CRISPRCas9_ Duchenne muscular dystrophy1-s2.0-S0024320523006380-main.pdfPublished version3.45 MB
Adobe PDF
Full metadata record
Please use this identifier to cite or link to this item: